Related references
Note: Only part of the references are listed.DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease
Marcia Maria de Souza et al.
CURRENT MEDICINAL CHEMISTRY (2023)
DYRK1A inhibitors for disease therapy: Current status and perspectives
Tong Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
KEGG mapping tools for uncovering hidden features in biological data
Minoru Kanehisa et al.
PROTEIN SCIENCE (2022)
UALCAN: An update to the integrated cancer data analysis platform
Darshan Shimoga Chandrashekar et al.
NEOPLASIA (2022)
Target-based anticancer indole derivatives and insight into structure-activity relationship: A mechanistic review update (2018-2021)
Ashima Dhiman et al.
ACTA PHARMACEUTICA SINICA B (2022)
SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells
Alan Alfano et al.
PHARMACEUTICS (2022)
βIII-Tubulin Gene Regulation in Health and Disease
Alastair M. P. Duly et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Oxidative Stress-Induced Growth Inhibitor (OSGIN1), a Target of X-Box-Binding Protein 1, Protects Palmitic Acid-Induced Vascular Lipotoxicity through Maintaining Autophagy
Chong-Sun Khoi et al.
BIOMEDICINES (2022)
An overview on the exploring the interaction of inorganic nanoparticles with microtubules for the advancement of cancer therapeutics
Weidong Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors
Filip Borys et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies
Arun Kanakkanthara et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Microtubule-Based Mitochondrial Dynamics as a Valuable Therapeutic Target in Cancer
Rosa Vona et al.
CANCERS (2021)
Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring
Damien Reita et al.
CANCERS (2021)
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC
Jian Huang et al.
ONCOGENE (2020)
The tubulin code and its role in controlling microtubule properties and functions
Carsten Janke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Microtubule-targeting agents and their impact on cancer treatment
Vladimir Cermak et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2020)
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Sha-Sha Cheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The HDOCK server for integrated protein-protein docking
Yumeng Yan et al.
NATURE PROTOCOLS (2020)
Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
Tan-Min Chin et al.
THERANOSTICS (2020)
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
Yiu To Yeung et al.
EBIOMEDICINE (2018)
Oxidative Stress and Cancer
James E. Klaunig
CURRENT PHARMACEUTICAL DESIGN (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer
Andrea Hinsch et al.
HUMAN PATHOLOGY (2017)
Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents
Anjana Devi Tangutur et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Role of OSGIN1 in mediating smoking-induced autophagy in the human airway epithelium
Guoqing Wang et al.
AUTOPHAGY (2017)
Mutations in Human Tubulin Proximal to the Kinesin-Binding Site Alter Dynamic Instability at Microtubule Plus- and Minus-Ends
Shih-Chieh Ti et al.
DEVELOPMENTAL CELL (2016)
Phosphorylation of β-Tubulin by the Down Syndrome Kinase, Minibrain/DYRK1a, Regulates Microtubule Dynamics and Dendrite Morphogenesis
Kassandra M. Ori-McKenney et al.
NEURON (2016)
Class III β-tubulin in normal and cancer tissues
Marisa Mariani et al.
GENE (2015)
TUBB3/βIII-Tubulin Acts through the PTEN/AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non-Small Cell Lung Cancer
Joshua A. McCarroll et al.
CANCER RESEARCH (2015)
Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells
Chun-Liang Tung et al.
EXPERIMENTAL CELL RESEARCH (2014)
Allele-Specific Imbalance of Oxidative Stress-Induced Growth Inhibitor 1 Associates With Progression of Hepatocellular Carcinoma
Ming Liu et al.
GASTROENTEROLOGY (2014)
Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
Robert M. Campbell et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Lung cancer: What are the links with oxidative stress, physical activity and nutrition
Edith Filaire et al.
LUNG CANCER (2013)
Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells
Jen-Chung Ko et al.
LUNG CANCER (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Interaction of OKL38 and p53 in Regulating Mitochondrial Structure and Function
Jing Hu et al.
PLOS ONE (2012)
Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2008)
The role of 5′ untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma
C. K. Ong et al.
ONCOGENE (2007)
Microtubule regulation in mitosis: Tubulin phosphorylation by the cyclin-dependent kinase Cdk1
A Fourest-Lieuvin et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis
CK Ong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Selective p38 activation in human non-small cell lung cancer
AK Greenberg et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics
A Gonçalves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)